Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 1 or 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Testing effectiveness (Phase 2)Study completedNCT00461136
What this trial is testing

Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes

Who this might be right for
Diabetes Type 2
Novartis 18
Large-scale testing (Phase 3)Study completedNCT00191581
What this trial is testing

Local Registration Trial in China Humalog Mix 50

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 120
Not applicableStudy completedNCT00665093
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,569
Not applicableLooking for participantsNCT07579702
What this trial is testing

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Who this might be right for
Type 2 Diabetes MellitusType 1 Diabetes Mellitus
Insulet Corporation 200
Not applicableStudy completedNCT07408141
What this trial is testing

MiniMed Fit Payload Wear Study

Who this might be right for
Diabetes (Insulin-requiring, Type 1 or Type 2)
Medtronic MiniMed, Inc. 159
Not applicableStudy completedNCT07386613
What this trial is testing

Feasibility of Home Monitoring of Visual Function in DR

Who this might be right for
Diabetes (DM)Diabetes ComplicationDiabetes (Insulin-requiring, Type 1 or Type 2)+4 more
Queen's University, Belfast 55
Early research (Phase 1)Study completedNCT02806973
What this trial is testing

Single or Repeated Doses of Glucagon in Participants With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Not applicableStudy completedNCT02105103
What this trial is testing

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Who this might be right for
Type 2 Diabetes, Type 1 Diabetes
Hoffmann-La Roche 80
Not applicableStudy completedNCT01542489
What this trial is testing

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 480
Testing effectiveness (Phase 2)Looking for participantsNCT06924320
What this trial is testing

MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Who this might be right for
Obesity and Obesity-related Medical Conditions
Pfizer 381
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Not applicableLooking for participantsNCT07463209
What this trial is testing

Integrating New Skills Into Diabetes Education With CGM

Who this might be right for
Insulin Dependent DiabetesDiabetes (DM)Diabetes (Insulin-requiring, Type 1 or Type 2)+4 more
University of North Carolina, Chapel Hill 144
Very early researchTemporarily pausedNCT06845943
What this trial is testing

A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes

Who this might be right for
Obesity and Overweight
Helicore Biopharma, Inc. 48
Not applicableStudy completedNCT00286572
What this trial is testing

Long-term Mortality in Diabetics Undergoing Major Surgery

Who this might be right for
Diabetes MellitusCoronary Heart DiseaseMajor Non-cardiac Surgery
University Hospital, Basel, Switzerland 380
Not applicableStudy completedNCT01961466
What this trial is testing

Diabetes and Psychological Profile

Who this might be right for
Type 1 or 2 Diabetes
Centre Hospitalier Universitaire Dijon 592
Large-scale testing (Phase 3)Study completedNCT01336023
What this trial is testing

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,663
Not applicableUnknownNCT04226846
What this trial is testing

Feasibility Trial of the Bios Device for Continuous Glucose Monitoring

Who this might be right for
Type 1 DiabetesType 2 Diabetes
GraphWear Technologies Inc. 50
Next Page